Literature DB >> 34073301

Refinement of an Established Procedure and Its Application for Identification of Hypoxia in Prostate Cancer Xenografts.

Pernille B Elming1, Thomas R Wittenborn1, Morten Busk2, Brita S Sørensen1,2, Mathilde Borg Houlberg Thomsen3,4, Trine Strandgaard3,4, Lars Dyrskjøt3,4, Steffen Nielsen1, Michael R Horsman1.   

Abstract

BACKGROUND: This pre-clinical study was designed to refine a dissection method for validating the use of a 15-gene hypoxia classifier, which was previously established for head and neck squamous cell carcinoma (HNSCC) patients, to identify hypoxia in prostate cancer.
METHODS: PC3 and DU-145 adenocarcinoma cells, in vitro, were gassed with various oxygen concentrations (0-21%) for 24 h, followed by real-time PCR. Xenografts were established in vivo, and the mice were injected with the hypoxic markers [18F]-FAZA and pimonidazole. Subsequently, tumors were excised, frozen, cryo-sectioned, and analyzed using autoradiography ([18F]-FAZA) and immunohistochemistry (pimonidazole); the autoradiograms used as templates for laser capture microdissection of hypoxic and non-hypoxic areas, which were lysed, and real-time PCR was performed.
RESULTS: In vitro, all 15 genes were increasingly up-regulated as oxygen concentrations decreased. With the xenografts, all 15 genes were up-regulated in the hypoxic compared to non-hypoxic areas for both cell lines, although this effect was greater in the DU-145.
CONCLUSIONS: We have developed a combined autoradiographic/laser-guided microdissection method with broad applicability. Using this approach on fresh frozen tumor material, thereby minimizing the degree of RNA degradation, we showed that the 15-gene hypoxia gene classifier developed in HNSCC may be applicable for adenocarcinomas such as prostate cancer.

Entities:  

Keywords:  DU-145; PC3; hypoxia; hypoxia gene signature; pre-clinical models; prostate cancer

Year:  2021        PMID: 34073301     DOI: 10.3390/cancers13112602

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  40 in total

1.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  Hypoxia positron emission tomography imaging: combining information on perfusion and tracer retention to improve hypoxia specificity.

Authors:  Morten Busk; Ole L Munk; Steen S Jakobsen; Michael R Horsman
Journal:  Acta Oncol       Date:  2017-08-25       Impact factor: 4.089

3.  Tumor tissue oxygenation as evaluated by computerized-pO2-histography.

Authors:  F Kallinowski; R Zander; M Hoeckel; P Vaupel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-10       Impact factor: 7.038

4.  The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types.

Authors:  Brita Singers Sørensen; Anders Knudsen; Catja Foged Wittrup; Steffen Nielsen; Ninna Aggerholm-Pedersen; Morten Busk; Michael Horsman; Morten Høyer; Pierre Nourdine Bouchelouche; Jens Overgaard; Jan Alsner
Journal:  Radiother Oncol       Date:  2015-07-10       Impact factor: 6.280

5.  Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model.

Authors:  M R Horsman; A A Khalil; M Nordsmark; C Grau; J Overgaard
Journal:  Radiother Oncol       Date:  1993-07       Impact factor: 6.280

Review 6.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response.

Authors:  Mark W Dewhirst; Yiting Cao; Benjamin Moeller
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

Review 7.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

Review 8.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 9.  The impact of hypoxia and its modification of the outcome of radiotherapy.

Authors:  Michael R Horsman; Jens Overgaard
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

10.  Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.

Authors:  Lingjian Yang; Darren Roberts; Mandeep Takhar; Nicholas Erho; Becky A S Bibby; Niluja Thiruthaneeswaran; Vinayak Bhandari; Wei-Chen Cheng; Syed Haider; Amy M B McCorry; Darragh McArt; Suneil Jain; Mohammed Alshalalfa; Ashley Ross; Edward Schaffer; Robert B Den; R Jeffrey Karnes; Eric Klein; Peter J Hoskin; Stephen J Freedland; Alastair D Lamb; David E Neal; Francesca M Buffa; Robert G Bristow; Paul C Boutros; Elai Davicioni; Ananya Choudhury; Catharine M L West
Journal:  EBioMedicine       Date:  2018-04-23       Impact factor: 8.143

View more
  1 in total

Review 1.  Accurate Three-Dimensional Thermal Dosimetry and Assessment of Physiologic Response Are Essential for Optimizing Thermoradiotherapy.

Authors:  Mark W Dewhirst; James R Oleson; John Kirkpatrick; Timothy W Secomb
Journal:  Cancers (Basel)       Date:  2022-03-27       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.